Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
BALAXI Stock Analysis
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
Low Debt to Equity, not much change from last year
Negative
Weak price momentum
Low and declining ROE
Low and declining operating margin
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Company's earnings are of low quality
Low dividend yield
Neutral
Not enough talking point with neutral stance
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
BALAXI Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
BALAXI Bulk, Block & Insider Trades
BALAXI Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Stock split
Stock split(1 : 5)Nominal value change from INR 10 to INR 2. Ex-date: 30th May 2024 Announced on: 28th Feb 2024
Company Profile
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, ... Read More
Key personnel
Mr. Ashish MaheshwariD
Executive Chairman of the Board, Managing Director
Mr. Amol Mantri
Chief Financial Officer
Mr. Pranav Maheshwari
Senior Vice President - Business Development
Mr. Mohith Kumar Khandelwal
Compliance Officer, Company Secretary
Mr. Jignesh Dinesh Kumar Shah
Finance Controller, Angola
Mr. Ram Chawla
Country Head, Angola
Mr. Bharat Jawarani
Sales Head, Dominican Republic
Mr. Manish Jumnani
Sales Head, Guatemala
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Balaxi Pharmaceuticals Ltd.?
The current share price of Balaxi Pharmaceuticals Ltd. is ₹ 25.44 as of 09 Jan 2026.
What is the PE ratio of Balaxi Pharmaceuticals Ltd.?
The Price-to-Earnings (PE) ratio of Balaxi Pharmaceuticals Ltd. is 9.69 as of the latest financial data.
What is the ROE and ROCE of Balaxi Pharmaceuticals Ltd.?
Balaxi Pharmaceuticals Ltd. has a Return on Equity (ROE) of 6.39% and a Return on Capital Employed (ROCE) of 7.36% as per the latest financial reports.
What is the market cap of Balaxi Pharmaceuticals Ltd.?
The market capitalization of Balaxi Pharmaceuticals Ltd. stands at ₹ 140.45 Cr.
What is the dividend yield of Balaxi Pharmaceuticals Ltd.?
The dividend yield of Balaxi Pharmaceuticals Ltd. is 0.00% based on the current market price.
What is the RSI of Balaxi Pharmaceuticals Ltd.?
The Relative Strength Index (RSI) of Balaxi Pharmaceuticals Ltd. is 28.61.
What is the FII and DII holding in Balaxi Pharmaceuticals Ltd.?
Foreign Institutional Investors (FII) hold 3.50% and Domestic Institutional Investors (DII) hold 0.02% of Balaxi Pharmaceuticals Ltd. shares.
What sector does Balaxi Pharmaceuticals Ltd. belong to?
Balaxi Pharmaceuticals Ltd. operates in the Healthcare sector.
What is the beta of Balaxi Pharmaceuticals Ltd. stock?
The beta of Balaxi Pharmaceuticals Ltd. stock is 0.73, indicating its volatility relative to the broader market.
